Hugh Tilson
Affiliations: | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Toxicology, Neuroscience BiologyGoogle:
"Hugh Tilson"Mean distance: 53433
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Geissbühler Y, Vile J, Koren G, et al. (2018) Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure. Therapeutic Advances in Neurological Disorders. 11: 1756286418804760 |
| Vannappagari V, Albano JD, Koram N, et al. (2015) Prenatal exposure to zidovudine and risk for ventricular septal defects and congenital heart defects: data from the Antiretroviral Pregnancy Registry. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 197: 6-10 |
| Vannappagari V, Koram N, Albano J, et al. (2015) Association between in utero zidovudine exposure and nondefect adverse birth outcomes: analysis of prospectively collected data from the Antiretroviral Pregnancy Registry. Bjog : An International Journal of Obstetrics and Gynaecology |
| Vannappagari V, Koram N, Albano J, et al. (2015) Abacavir and lamivudine exposures during pregnancy and non-defect adverse pregnancy outcomes: data from the antiretroviral pregnancy registry. Journal of Acquired Immune Deficiency Syndromes (1999). 68: 359-64 |
| Kuemmerle-Deschner J, Hoffman H, Hawkins P, et al. (2015) SAT0524 Evaluation of Long-Term Safety and Effectiveness of Canakinumab Therapy in Patients with Cryopyrin-Associated Periodic Syndrome: Results from Beta-Confident Registry Annals of the Rheumatic Diseases. 74: 850-850 |
| Albano JD, Tilson H. (2013) No evidence for increased risk of cleft lip or cleft palate among infants exposed to antiretroviral drugs during pregnancy in the antiretroviral pregnancy registry. The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association. 50: 376-7 |
| Esker S, Albano J, Uy J, et al. (2012) Monitoring the risk of birth defects associated with atazanavir exposure in pregnancy. Aids Patient Care and Stds. 26: 307-11 |
| Huang HY, Andrews E, Jones J, et al. (2011) Pitfalls in meta-analyses on adverse events reported from clinical trials. Pharmacoepidemiology and Drug Safety. 20: 1014-20 |
| Esker S, Albano J, Tilson H, et al. (2010) Assessing the risk of birth defects associated with atazanavir exposure in pregnancy Journal of the International Aids Society. 13: 113 |
| Platt R, Madre L, Reynolds R, et al. (2008) Active drug safety surveillance: a tool to improve public health. Pharmacoepidemiology and Drug Safety. 17: 1175-82 |